F2 Capital I 2019, LLC 4
Accession 0000899243-19-024208
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 8:27 PM ET
Size
41.9 KB
Accession
0000899243-19-024208
Insider Transaction Report
- Sale
Common Stock
2019-09-20$17.94/sh−24,446$438,449→ 175,554 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−197,343$3,539,426→ 1,417,172 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−54,907$984,779→ 394,300 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−65,633$1,177,154→ 471,299 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,535$26,573→ 392,765 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,835$31,766→ 469,464 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−50,134$899,173→ 360,034 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−683$11,824→ 174,871 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−12,537$224,856→ 90,026 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−351$6,076→ 89,675 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,401$24,253→ 358,633 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−5,516$95,490→ 1,411,656 total(indirect: By Fund)
- 193,742(indirect: By Fund)
Common Stock
- Sale
Common Stock
2019-09-20$17.94/sh−12,537$224,856→ 90,026 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,835$31,766→ 469,464 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,401$24,253→ 358,633 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−683$11,824→ 174,871 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−54,907$984,779→ 394,300 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−24,446$438,449→ 175,554 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−65,633$1,177,154→ 471,299 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−50,134$899,173→ 360,034 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−197,343$3,539,426→ 1,417,172 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,535$26,573→ 392,765 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−351$6,076→ 89,675 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−5,516$95,490→ 1,411,656 total(indirect: By Fund)
- 193,742(indirect: By Fund)
Common Stock
- Sale
Common Stock
2019-09-20$17.94/sh−54,907$984,779→ 394,300 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−50,134$899,173→ 360,034 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,835$31,766→ 469,464 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−12,537$224,856→ 90,026 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−683$11,824→ 174,871 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,401$24,253→ 358,633 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−24,446$438,449→ 175,554 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−65,633$1,177,154→ 471,299 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−197,343$3,539,426→ 1,417,172 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,535$26,573→ 392,765 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−351$6,076→ 89,675 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−5,516$95,490→ 1,411,656 total(indirect: By Fund)
- 193,742(indirect: By Fund)
Common Stock
- Sale
Common Stock
2019-09-20$17.94/sh−24,446$438,449→ 175,554 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−12,537$224,856→ 90,026 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,401$24,253→ 358,633 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−50,134$899,173→ 360,034 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,835$31,766→ 469,464 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−54,907$984,779→ 394,300 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,535$26,573→ 392,765 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−683$11,824→ 174,871 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−65,633$1,177,154→ 471,299 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−197,343$3,539,426→ 1,417,172 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−351$6,076→ 89,675 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−5,516$95,490→ 1,411,656 total(indirect: By Fund)
- 193,742(indirect: By Fund)
Common Stock
- Sale
Common Stock
2019-09-23$17.31/sh−1,535$26,573→ 392,765 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−24,446$438,449→ 175,554 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−50,134$899,173→ 360,034 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−65,633$1,177,154→ 471,299 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−683$11,824→ 174,871 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,835$31,766→ 469,464 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−54,907$984,779→ 394,300 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−12,537$224,856→ 90,026 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,401$24,253→ 358,633 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−5,516$95,490→ 1,411,656 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−197,343$3,539,426→ 1,417,172 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−351$6,076→ 89,675 total(indirect: By Fund)
- 193,742(indirect: By Fund)
Common Stock
- Sale
Common Stock
2019-09-20$17.94/sh−12,537$224,856→ 90,026 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−50,134$899,173→ 360,034 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−197,343$3,539,426→ 1,417,172 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,535$26,573→ 392,765 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−351$6,076→ 89,675 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,835$31,766→ 469,464 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−54,907$984,779→ 394,300 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−24,446$438,449→ 175,554 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−65,633$1,177,154→ 471,299 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−683$11,824→ 174,871 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,401$24,253→ 358,633 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−5,516$95,490→ 1,411,656 total(indirect: By Fund)
- 193,742(indirect: By Fund)
Common Stock
- Sale
Common Stock
2019-09-20$17.94/sh−54,907$984,779→ 394,300 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−65,633$1,177,154→ 471,299 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−683$11,824→ 174,871 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,401$24,253→ 358,633 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−24,446$438,449→ 175,554 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−50,134$899,173→ 360,034 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,835$31,766→ 469,464 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,535$26,573→ 392,765 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−12,537$224,856→ 90,026 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−197,343$3,539,426→ 1,417,172 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−351$6,076→ 89,675 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−5,516$95,490→ 1,411,656 total(indirect: By Fund)
- 193,742(indirect: By Fund)
Common Stock
- Sale
Common Stock
2019-09-20$17.94/sh−12,537$224,856→ 90,026 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−683$11,824→ 174,871 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−50,134$899,173→ 360,034 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,835$31,766→ 469,464 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−54,907$984,779→ 394,300 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−24,446$438,449→ 175,554 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−65,633$1,177,154→ 471,299 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−197,343$3,539,426→ 1,417,172 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,401$24,253→ 358,633 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,535$26,573→ 392,765 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−351$6,076→ 89,675 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−5,516$95,490→ 1,411,656 total(indirect: By Fund)
- 193,742(indirect: By Fund)
Common Stock
- Sale
Common Stock
2019-09-20$17.94/sh−54,907$984,779→ 394,300 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−12,537$224,856→ 90,026 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−65,633$1,177,154→ 471,299 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−683$11,824→ 174,871 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−5,516$95,490→ 1,411,656 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−24,446$438,449→ 175,554 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−197,343$3,539,426→ 1,417,172 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,535$26,573→ 392,765 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−351$6,076→ 89,675 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,835$31,766→ 469,464 total(indirect: By Fund) - Sale
Common Stock
2019-09-20$17.94/sh−50,134$899,173→ 360,034 total(indirect: By Fund) - Sale
Common Stock
2019-09-23$17.31/sh−1,401$24,253→ 358,633 total(indirect: By Fund)
- 193,742(indirect: By Fund)
Common Stock
Footnotes (7)
- [F1]The reported securities are owned directly by F2 MG Limited. Globeways Holdings Limited is the appointed manager of F2 MG Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
- [F2]The reported securities are owned directly by F2 BBG LLC. Globeways Holdings II Limited is the appointed manager of F2 BBG LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 BBG LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
- [F3]The reported securities are owned directly by F2 Capital I 2019, LLC. Globeways Holdings II Limited is the appointed manager of F2 Capital I 2019, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2019, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
- [F4]The reported securities are owned directly F2-TPO Investments, LLC. Globeways Holdings Limited is the appointed manager of F2-TPO Investments, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO Investments, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
- [F5]The reported securities are owned directly by F2 Capital I 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2017 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
- [F6]The reported securities are owned directly by F2 Capital I 2015 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2015 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2015 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
- [F7]The reported securities are owned directly by F2 Bioscience II 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Bioscience II 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bioscience II 2017 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
Documents
Issuer
TCR2 THERAPEUTICS INC.
CIK 0001750019
Related Parties
1- filerCIK 0001767418
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 8:27 PM ET
- Size
- 41.9 KB